Non-Compartmental and Compartmental Approaches to Pharmacokinetic Data Analysis

The evaluation of pharmacokinetic parameters is an essential part of understanding how drugs function in the body. To estimate these parameters, studies are undertaken in which time-dependent measurements are collected. These studies can be conducted in animals at the preclinical level, through all stages of clinical trials, and can be data rich or sparse. No matter what the situation, there must be some common means by which to communicate the experimental results and summarize key features of a drug’s properties. Pharmacokinetic parameters serve this purpose. Thus, in the field of pharmacokinetics, the definitions and formulas for the parameters must be agreed upon, and the methods used to calculate them understood. This understanding includes assumptions and domains of validity, for the utility of the parameter values depends upon them. This chapter examines the assumptions and domains of validity for the two commonly used methods of pharmacokinetic modeling analysis – non-compartmental and compartmental. Compartmental models have been presented in earlier chapters. This chapter will expand upon this, and compare the two methods.

[1]  Kiyoshi Yamaoka,et al.  Statistical moments in pharmacokinetics , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  Y. Sugiyama,et al.  Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo. , 1998, The Journal of pharmacology and experimental therapeutics.

[3]  K. Zierler Theory of Use of Indicators to Measure Blood Flow and Extracellular Volume and Calculation of Transcapillary Movement of Tracers , 1963 .

[4]  Charles DeLisi,et al.  Mean residence time—theoretical development, experimental determination, and practical use in tracer analysis☆ , 1984 .

[5]  J J DiStefano,et al.  Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. , 1984, The American journal of physiology.

[6]  Comments on mean residence time determination , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[7]  P Veng-Pedersen,et al.  Noncompartmentally-based pharmacokinetic modeling. , 2001, Advanced drug delivery reviews.

[8]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[9]  Claudio Cobelli,et al.  Tracer Kinetics in Biomedical Research: From Data to Model , 2013 .

[10]  M Berman,et al.  Kinetic analysis of turnover data. , 1979, Progress in biochemical pharmacology.

[11]  L. Benet Clearance (née Rowland) concepts: a downdate and an update , 2010, Journal of Pharmacokinetics and Pharmacodynamics.

[12]  K. C. Yeh,et al.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[13]  M. Weiss,et al.  Pharmacokinetic model based on circulatory transport , 1979, European Journal of Clinical Pharmacology.

[14]  J J DiStefano,et al.  Multiexponential, multicompartmental, and noncompartmental modeling. I. Methodological limitations and physiological interpretations. , 1984, The American journal of physiology.

[15]  A. Rescigno,et al.  Estimation of Permanence Time, Exit Time, Dilution Factor, and Steady-State Volume of Distribution , 2004, Pharmaceutical Research.

[16]  Fundamental concepts in pharmacokinetics. , 1997, Pharmacological research.

[17]  J N Weinstein,et al.  Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. , 1986, Cancer research.

[18]  J J Distefano,et al.  DIMSUM: an expert system for multiexponential model discrimination. , 1992, The American journal of physiology.

[19]  S. Beal Some clarifications regarding moments of residence times with pharmacokinetic models , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[20]  K. Zierler,et al.  THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES. , 1961, The Journal of clinical investigation.

[21]  W R Gillespie,et al.  Noncompartmental Versus Compartmental Modelling in Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.

[22]  R. Hansen,et al.  Antibody pharmacokinetics and pharmacodynamics. , 2004, Journal of pharmaceutical sciences.

[23]  R. Purves,et al.  Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC) , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  J J DiStefano,et al.  Noncompartmental vs. compartmental analysis: some bases for choice. , 1982, The American journal of physiology.

[25]  R. Schoenfeld,et al.  Invariants in Experimental Data on Linear Kinetics and the Formulation of Models , 1956 .

[26]  J. Wagner Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[27]  Karl Pearson,et al.  ON THE SYSTEMATIC FITTING OF CURVES TO OBSERVATIONS AND MEASUREMENTS , 1902 .

[28]  C. Cobelli,et al.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.

[29]  F P Chinard,et al.  Indicator equivalence theorem for input rates and regional masses in multi-inlet steady-state systems with partially labeled input. , 1969, Journal of theoretical biology.

[30]  D. Katz,et al.  Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies. , 1983, Biometrics.

[31]  M. Weiss,et al.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts , 2007, The AAPS Journal.

[32]  A Rescigno,et al.  The rise and fall of compartmental analysis. , 2001, Pharmacological research.

[33]  C Cobelli,et al.  Compartmental vs. noncompartmental modeling for two accessible pools. , 1984, The American journal of physiology.

[34]  K. Norwich Noncompartmental models of whole-body clearance of tracers: A review , 1997, Annals of Biomedical Engineering.

[35]  Ivan Nestorov,et al.  Whole Body Pharmacokinetic Models , 2003, Clinical pharmacokinetics.

[36]  Joseph J. DiStefanoIII Concepts, properties, measurement, and computation of clearance rates of hormones and other substances in biological systems , 1976 .

[37]  John A. Jacquez,et al.  Qualitative Theory of Compartmental Systems , 1993, SIAM Rev..

[38]  J. Jacquez Compartmental analysis in biology and medicine , 1985 .

[39]  D. Mager Target-mediated drug disposition and dynamics. , 2006, Biochemical pharmacology.

[40]  A Mari,et al.  Circulatory models of intact-body kinetics and their relationship with compartmental and non-compartmental analysis. , 1993, Journal of theoretical biology.

[41]  Johan Gabrielsson,et al.  Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .

[42]  M. Weiss,et al.  The relevance of residence time theory to pharmacokinetics , 2005, European Journal of Clinical Pharmacology.

[43]  A. John Bailer,et al.  Testing for the equality of area under the curves when using destructive measurement techniques , 1988, Journal of Pharmacokinetics and Biopharmaceutics.